Results. In the first cohort, the mean (SD) age of the 1004 residents was 81.3 (10.9) years, and 755 (75.2%) were female. Of the 1004 residents, 231 (23.0%) used a PPI at baseline and 283 (28.2%) died during the 12-month follow-up. The mortality rate was 33.3% (n = 77) and 26.6% (n=206) among users and nonusers of PPIs, respectively (P=.048). After adjusting for age, sex, comorbidity, and malnutrition, PPIs were associated with a 37% increased mortality (HR, 1.37; 95% CI, 1.05-1.78) (Table) . In the second cohort, the mean (SD) age of the 425 residents was 86.1 (7.0) years, and 347 residents (81.6%) were female. Of the 425 residents, 91 (21.4%) used a PPI at baseline and 106 (24.9%) died during the 12-month follow-up. The mortality rate was 36.3% (n=33) and 21.9% (n=73) among users and nonusers of PPIs, respectively (P=.005). After adjusting for age, sex, comorbidity, and delirium, PPIs were associated with an 82% increased mortality (HR, 1.82; 95% CI, 1.20-2.78).
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